These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33109571)

  • 21. Transgenic expression of S100A2 in hairless mouse skin enhances Cxcl13 mRNA in response to solar-simulated radiation.
    Li Y; Gudjonsson JE; Woods TL; Zhang T; Johnston A; Stoll SW; Elder JT
    Arch Dermatol Res; 2009 Mar; 301(3):205-17. PubMed ID: 18773213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma.
    Wang J; Ren Y; Guo X; Cheng H; Ye Y; Qi J; Yang C; You H
    Mol Med Rep; 2015 May; 11(5):3585-92. PubMed ID: 25571919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protumorigenic actions of S100A2 involve regulation of PI3/Akt signaling and functional interaction with Smad3.
    Naz S; Bashir M; Ranganathan P; Bodapati P; Santosh V; Kondaiah P
    Carcinogenesis; 2014 Jan; 35(1):14-23. PubMed ID: 23996929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S100A2, a putative tumor suppressor gene, regulates in vitro squamous cell carcinoma migration.
    Nagy N; Brenner C; Markadieu N; Chaboteaux C; Camby I; Schäfer BW; Pochet R; Heizmann CW; Salmon I; Kiss R; Decaestecker C
    Lab Invest; 2001 Apr; 81(4):599-612. PubMed ID: 11304580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
    Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
    Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis.
    Feng G; Xu X; Youssef EM; Lotan R
    Cancer Res; 2001 Nov; 61(21):7999-8004. PubMed ID: 11691825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and clinicopathological significance of S100 calcium binding protein A2 in lung cancer patients of Chinese Han ethnicity.
    Wang T; Liang Y; Thakur A; Zhang S; Liu F; Khan H; Shi P; Wang N; Chen M; Ren H
    Clin Chim Acta; 2017 Jan; 464():118-122. PubMed ID: 27876462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
    Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
    J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic silencing of ZBTB28 promotes renal cell carcinogenesis.
    Tong X; Xu L; Rong R; Su X; Xiang T; Peng W; Shi T
    Asia Pac J Clin Oncol; 2022 Apr; 18(2):e79-e86. PubMed ID: 34161675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
    Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
    Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas.
    Malouf GG; Su X; Zhang J; Creighton CJ; Ho TH; Lu Y; Raynal NJ; Karam JA; Tamboli P; Allanick F; Mouawad R; Spano JP; Khayat D; Wood CG; Jelinek J; Tannir NM
    Clin Cancer Res; 2016 Dec; 22(24):6236-6246. PubMed ID: 27256309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes.
    Winter S; Fisel P; Büttner F; Rausch S; D'Amico D; Hennenlotter J; Kruck S; Nies AT; Stenzl A; Junker K; Scharpf M; Hofmann U; van der Kuip H; Fend F; Ott G; Agaimy A; Hartmann A; Bedke J; Schwab M; Schaeffeler E
    Sci Rep; 2016 Jul; 6():29930. PubMed ID: 27435027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of altered S100A2 expression in gastric cancer.
    Zhao Y; Zhang TB; Wang Q
    Oncol Rep; 2013 Apr; 29(4):1556-62. PubMed ID: 23337980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Proteomic Analysis of Human Cholangiocarcinoma Cell Lines: S100A2 as a Potential Candidate Protein Inducer of Invasion.
    Wasuworawong K; Roytrakul S; Paemanee A; Jindapornprasert K; Komyod W
    Dis Markers; 2015; 2015():629367. PubMed ID: 25999659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of calcium-binding protein S100A2 in breast lesions.
    Liu D; Rudland PS; Sibson DR; Platt-Higgins A; Barraclough R
    Br J Cancer; 2000 Dec; 83(11):1473-9. PubMed ID: 11076656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of S100A2 as a target of the DeltaNp63 oncogenic pathway.
    Hibi K; Fujitake S; Takase T; Kodera Y; Ito K; Akiyama S; Shirane M; Nakao A
    Clin Cancer Res; 2003 Sep; 9(11):4282-5. PubMed ID: 14519656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of RASSF1A tumor suppressor gene is associated with worse prognosis in clear cell renal cell carcinoma.
    Klacz J; Wierzbicki PM; Wronska A; Rybarczyk A; Stanislawowski M; Slebioda T; Olejniczak A; Matuszewski M; Kmiec Z
    Int J Oncol; 2016 Jan; 48(1):55-66. PubMed ID: 26648328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site.
    Kirschner RD; Sänger K; Müller GA; Engeland K
    Nucleic Acids Res; 2008 May; 36(9):2969-80. PubMed ID: 18388131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S100A2 in cancerogenesis: a friend or a foe?
    Wolf S; Haase-Kohn C; Pietzsch J
    Amino Acids; 2011 Oct; 41(4):849-61. PubMed ID: 20521072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.